Showing results (431-440 of 1,343) with videos related to

Sort By:
Pageof 135
The Pharmacogenomics Journal|April 7, 2010
Impact of CYP2C8*3 on paclitaxel clearance: a population pharmacokinetic and pharmacogenomic study in 93 patients with ovarian cancerT K Bergmann, C Brasch-Andersen, H Gréen, et al.
The Pharmacogenomics Journal|April 22, 2009
Pharmacogenetics and biomarkers in colorectal cancerA S Strimpakos, K N Syrigos, M W Saif
The Pharmacogenomics Journal|April 15, 2009
A novel CYP2A6 allele (CYP2A6*35) resulting in an amino-acid substitution (Asn438Tyr) is associated with lower CYP2A6 activity in vivoNael Al Koudsi, Jasjit S Ahluwalia, Shih-Ku Lin, et al.
The Pharmacogenomics Journal|February 24, 2010
Prediction of irinotecan and 5-fluorouracil toxicity and response in patients with advanced colorectal cancerB Glimelius, H Garmo, A Berglund, et al.
The Pharmacogenomics Journal|June 14, 2017
Cost-effectiveness of pharmacogenetic-guided treatment: are we there yet?M Verbelen, M E Weale, C M Lewis
The Pharmacogenomics Journal|September 28, 2016
Genes differentially expressed by methylprednisolone in vivo in CD4 T lymphocytes from multiple sclerosis patients: potential biomarkersC De Andres, M I García, H Goicoechea, et al.
The Pharmacogenomics Journal|July 12, 2017
Genome-wide meta-analysis of copy number variations with alcohol dependenceA Sulovari, Z Liu, Z Zhu, et al.
The Pharmacogenomics Journal|July 12, 2017
Genome-wide association studies of placebo and duloxetine response in major depressive disorderM Maciukiewicz, V S Marshe, A K Tiwari, et al.
Pageof 135